• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

North American Partners in Anesthesia (NAPA) Acquires American Anesthesiology From MEDNAX, Inc., to Create One of the Most Comprehensive Anesthesia, Pain Management, and Perioperative Care Companies in the U.S.

Share:

May 11, 2020

North American Partners in Anesthesia (NAPA) and MEDNAX, Inc. (NYSE: MD) today jointly announced the completion of NAPA’s acquisition of American Anesthesiology, a MEDNAX medical group, creating the destination of choice for anesthesia, pain management, and perioperative care in the United States.

NAPA was founded in 1986 by physicians with a mission to seek excellence in patient care and create value for its clinicians and hospital and ambulatory partners. That vision has helped the company grow from coast to coast. American Anesthesiology, founded in 2007, has grown into a leading and dynamic anesthesia partner, providing comprehensive, customized health solutions in a variety of clinical settings, which is well aligned with NAPA’s mission and vision. With this transaction, NAPA will now employ, through its affiliated entities, over 6,000 clinicians and staff who deliver quality anesthesia and pain management services, at more than 500 facilities in 20 states and the District of Columbia, to over three million patients annually.

John F. Di Capua, M.D., Chief Executive Officer of NAPA, said, “In welcoming American Anesthesiology’s clinicians and administrative team members to the NAPA family today, we are solidifying our role as the destination of choice for anesthesia, pain management, and perioperative care in the United States. Importantly, American Anesthesiology shares our commitment to putting patients first, and their clinicians will join us as we focus on delivering exceptional patient outcomes under our clinician-led, single-specialty model. We look forward to learning from, and collaborating with, our new colleagues as we leverage our combined expertise and resources to elevate the industry standard among our patients, clinicians, surgeons and hospital and ambulatory partners.”

“Anesthesiology clinicians are part of the backbone of the healthcare industry, and at no time has that been more evident than during this pandemic crisis,” said Roger J. Medel, M.D., Chief Executive Officer of MEDNAX. “This transaction enables American Anesthesiology to become part of a clinician-led, clinically focused, single-specialty organization dedicated to the provision of high-quality anesthesia, pain management, and perioperative care. At MEDNAX, we will remain focused on the care we provide and the opportunities available for growth in our Pediatrix & Obstetrix and MEDNAX Radiology Solutions medical groups, as well as Surgical Directions.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Dr. Di Capua concluded, “Our proven best practices from our combined organization, regionally-oriented dyad structure, data driven anesthesia services and innovative technology will all now be able to be deployed on a greater scale. This will enable us to create value for our partners across the country and reinvest in the business to ensure that our clinicians stay at the forefront of anesthesiology to deliver the best patient care.”

Further details of the transaction, including financial terms, can be found in a Current Report on Form 8-K filed by MEDNAX today with the Securities and Exchange Commission.

In connection with this transaction, and in order to facilitate a seamless transition for American Anesthesiology’s clinicians and employees, MEDNAX has agreed to provide certain transition services for up to 18 months.

Source: BioSpace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Novanta Announces Agreement to Acquire ATINovanta Announces Agreement to Acquire ATI
  • Eko Awarded $2.7M NIH Grant for Heart Murmur & Valvular Heart Disease Detection AlgorithmsEko Awarded $2.7M NIH Grant for Heart Murmur & Valvular Heart Disease Detection Algorithms
  • CervoMed Announces Completion of Merger with EIP PharmaCervoMed Announces Completion of Merger with EIP Pharma
  • Caregiver Mental Health Platform Family First Secures $11M and More Digital Health Fundings.Caregiver Mental Health Platform Family First Secures $11M and More Digital Health Fundings.
  • ‘innovation is Birthed in Chaos’: Why Startups Should be Considering a Covid-19 Pivot‘innovation is Birthed in Chaos’: Why Startups Should be Considering a Covid-19 Pivot
  • Bayer Completes Acquisition of the UK-Based Biotech Company Kandy Therapeutics Ltd.Bayer Completes Acquisition of the UK-Based Biotech Company Kandy Therapeutics Ltd.
  • Eloxx Pharmaceuticals Acquires Zikani TherapeuticsEloxx Pharmaceuticals Acquires Zikani Therapeutics
  • Consumerism, value-based care and the supply chain: How 4 disruptive technologies are changing healthcareConsumerism, value-based care and the supply chain: How 4 disruptive technologies are changing healthcare

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications